001469740 000__ 05470cam\\2200649\i\4500
001469740 001__ 1469740
001469740 003__ OCoLC
001469740 005__ 20230803003344.0
001469740 006__ m\\\\\o\\d\\\\\\\\
001469740 007__ cr\un\nnnunnun
001469740 008__ 230618s2023\\\\si\a\\\\ob\\\\000\0\eng\d
001469740 019__ $$a1382693192
001469740 020__ $$a9789819921393$$q(electronic bk.)
001469740 020__ $$a9819921392$$q(electronic bk.)
001469740 020__ $$z9789819921386
001469740 020__ $$z9819921384
001469740 0247_ $$a10.1007/978-981-99-2139-3$$2doi
001469740 035__ $$aSP(OCoLC)1382689854
001469740 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dN$T
001469740 049__ $$aISEA
001469740 050_4 $$aR857.N34
001469740 08204 $$a610.282$$223/eng/20230623
001469740 1001_ $$aSelvan, Subramanian Tamil,$$eauthor.
001469740 24510 $$aNanomedicine :$$bemerging prospects /$$cSubramanian Tamil Selvan.
001469740 264_1 $$aSingapore :$$bSpringer,$$c[2023]
001469740 264_4 $$c©2023
001469740 300__ $$a1 online resource (vi, 73 pages) :$$billustrations (chiefly color).
001469740 336__ $$atext$$btxt$$2rdacontent
001469740 337__ $$acomputer$$bc$$2rdamedia
001469740 338__ $$aonline resource$$bcr$$2rdacarrier
001469740 4901_ $$aSpringerBriefs in applied sciences and technology. Nanotheranostics
001469740 504__ $$aIncludes bibliographical references.
001469740 5050_ $$aIntro -- Contents -- 1 Introduction to Nanomedicine -- 1.1 Nanomedicine -- 1.1.1 Nanomaterials for Cancer Nanomedicine -- 1.2 Challenges and Advancements of Nanomaterials for Nanomedicine -- 1.2.1 Nanomedicine Advancements in Cancer and Neurodegenerative Diseases -- 1.2.2 Nanomedicine Advancements in Orthopaedics and Cardiovascular Diseases -- References -- 2 Cancer Nanomedicine -- 2.1 Emerging QDs and NPs as Bioimaging Probes -- 2.1.1 NIR Emitting QDs for Deep-Tissue Bimodal Imaging -- 2.1.2 Au-NPs and Tripods for Bioimaging and Therapy -- 2.2 NPs as Drug Carriers -- 2.2.1 Iron Oxide NPs
001469740 5058_ $$a2.2.2 Silica-Based Carriers -- 2.2.3 Graphene and Graphene Oxide as Carriers -- 2.2.4 Peptide/Polymer Mediated Delivery -- 2.2.5 Liposomes for Targeted Delivery -- 2.3 Photothermal Therapy -- References -- 3 Nanomedicine for Neurodegenerative Diseases -- 3.1 Design of NPs for Inhibiting Protein Aggregation -- 3.1.1 Au NPs -- 3.1.2 Ceria NPs -- 3.2 NP-Based Drug Delivery Carriers -- 3.2.1 Apolipoprotein -- 3.2.2 Dendrimers, Peptides, and Inorganic NPs -- 3.3 NP-Based Biosensors for AD Diagnosis -- References -- 4 Nanomedicine for Orthopaedics -- 4.1 Nanoscale Materials for Bone Tissue Regeneration
001469740 5058_ $$a4.1.1 Natural Polymers Based Scaffolds for Bone Regeneration -- 4.1.2 Hydroxyapatite and Graphene Oxide Scaffolds for Bone Regeneration -- 4.1.3 Antibacterial Nanoparticles Coated Orthopaedic Implants -- 4.2 Hydrogel Scaffolds for Osteogenic Differentiation of Stem Cells -- 4.2.1 Polymer/Stem Cells Implanted Hydrogels for Cartilage Regeneration -- 4.3 Nanomedicine for Controlled Orthopaedic Drug Delivery -- References -- 5 Nanomedicine for Cardiac Diseases -- 5.1 Nanomedicine for Diagnostics and Therapeutics of CVDs -- 5.1.1 Nanomedicine for Cardiac Tissue Repair and Reinforcement
001469740 5058_ $$a5.1.2 Nanocarriers for Cardiac Delivery of Drugs and MicroRNA -- 5.2 Nanotechnology Assisted Cardiac Regenerative Medicine -- 5.2.1 Dextran NPs Assisted Dual Drug Delivery for Cardiac Regeneration -- 5.2.2 Nanotherapeutic Approach for Alleviating Cardiac Brain Injury -- 5.2.3 Nanoparticle-Based Composite Patch for Myocardial Infarction -- References -- 6 Conclusions and Perspectives -- References
001469740 506__ $$aAccess limited to authorized users.
001469740 520__ $$aThis book highlights the emerging paradigm of nanomedicine, intersecting two burgeoning fields of nanotechnology and medicine. Numerous publications have appeared in the literature over the years, especially in cancer nanomedicine. In a boarder sense, nanomedicine aims to apply the knowledge and tools of nanotechnology in a mission to diagnose early and prevent or treat diseases using biocompatible nanoparticles (NPs). Current research in nanomedicine and its prospects depend on creating new breakthroughs at the nexus of nanomaterials and biological systems, making use of non-toxic NPs and nano/biomaterials as smart theranostic systems for a variety of diseases including cancer, neurodegenerative, orthopedic, and cardiac diseases. This book provides a review on recent advancements of nanomedicine in the aforementioned emerging areas of nanomedicine.
001469740 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed June 23, 2023).
001469740 650_0 $$aNanomedicine$$xTechnological innovations.
001469740 655_0 $$aElectronic books.
001469740 77608 $$iPrint version:$$z9819921384$$z9789819921386$$w(OCoLC)1373608604
001469740 830_0 $$aSpringerBriefs in applied sciences and technology.$$pNanotheranostics.
001469740 852__ $$bebk
001469740 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-99-2139-3$$zOnline Access$$91397441.1
001469740 909CO $$ooai:library.usi.edu:1469740$$pGLOBAL_SET
001469740 980__ $$aBIB
001469740 980__ $$aEBOOK
001469740 982__ $$aEbook
001469740 983__ $$aOnline
001469740 994__ $$a92$$bISE